The pharmacy, a national compounding leader, unveils its Thesis brand, emphasizing scientific rigor, personalized medicine, and compassionate care.

Thesis Pharmacy today announced its official rebrand from Texas Star Pharmacy, marking a major milestone in its growth as a leading national compounding provider licensed in over 40 states. Co-owners Raman and Jay Bhaumik selected the name Thesis Pharmacy to reflect its foundation in research, precision, and purpose-driven care.

The rebrand underscores the company’s commitment to clinical excellence, quality compounding, and innovative, personalized solutions. Thesis Pharmacy continues to serve providers and patients with evidence-based formulations, rigorous testing, and a human-centered approach.

“A thesis is a clear, evidence-supported statement, and that’s how we practice pharmacy,” said Dr. Jay Bhaumik, Chairman. “This name captures our dedication to scientific integrity, elevated standards, and solutions crafted with accuracy and compassion.”

As the company expands nationally, it remains focused on comprehensive service, quality control, and personalized medicine that addresses diverse patient needs. Raman Bhaumik, pharmacist and Chief People Officer, adds, “Our mission has always been grounded in precision, trust, and compassion. This brand reflects where we are today and where we are headed—innovation, patient advocacy, and improved health outcomes.”

Thesis Pharmacy confirms that its services, staff, and dedication to patients remain unchanged. Providers and patients can expect continued access to pharmacist-led guidance, compliant formulations, and a growing portfolio of customized medications and nutraceuticals. The rebrand symbolizes advancement while preserving trusted relationships built over years of service nationwide.

Jay Bhaumik, Chairman of Thesis Pharmacy, is an entrepreneur and manufacturing innovator with over 20 years in pharma, IT, cybersecurity, real estate, and healthcare. Based in Frisco, Texas, he is known for combining innovation with strategic growth and community impact.

Raman Bhaumik is a healthcare executive and licensed pharmacist with expertise in pharmacy management, operations, and strategic planning. Her focus on process improvement and mentorship has strengthened the organization’s national presence and cultivated future healthcare leaders.

Thesis Pharmacy is a leading provider of compounded medications, dedicated to delivering high-quality, personalized pharmaceutical care. The company combines advanced compounding techniques, clinical expertise, and compassionate service to meet the unique needs of patients and healthcare providers across the nation.

For more information about Thesis Pharmacy, visit https://thesispharmacy.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251125310333/en/